Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 · Journal of Clinical Oncology · 4,815 citations
https://doi.org/10.1200/jco.2008.18.1370
D
David Voduc
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
11.8K
Citations
17
h-index
20
i10-index
David Voduc is an academic researcher. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Estrogen and related hormone effects. The author has an h-index of 17, co-authored 32 publications.
Papers by this author
worksKi67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 · JNCI Journal of the National Cancer Institute · 2,199 citations
https://doi.org/10.1093/jnci/djp082
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases
2007 · Breast Cancer Research and Treatment · 218 citations
https://doi.org/10.1007/s10549-007-9546-3
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
2015 · The Oncologist · 194 citations
https://doi.org/10.1634/theoncologist.2014-0372
Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy
2015 · Journal of Clinical Oncology · 138 citations
https://doi.org/10.1200/jco.2014.57.7999
HER-3 Overexpression Is Prognostic of Reduced Breast Cancer Survival
2010 · Annals of Surgery · 60 citations
https://doi.org/10.1097/sla.0b013e3181dbb77e
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat